Status:
RECRUITING
Innate Immunity in Allergic Asthma
Lead Sponsor:
University of Central Florida
Conditions:
Asthma
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to determine whether a potential type 2 signature, obtained through stimulation of cell lines with various allergens in vitro, correlates with an allergic or asthmatic dis...
Eligibility Criteria
Inclusion
- Participants must be at least 18 years of age
- no history of allergic disease (healthy controls), have clinically diagnosed allergies, or have clinically diagnosed asthma.
Exclusion
- Pregnant women and prisoners will be excluded from the study.
- Individuals currently suffering from any acute infections and those known to suffer from light-headedness will be excluded.
Key Trial Info
Start Date :
October 18 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2025
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06068335
Start Date
October 18 2021
End Date
June 1 2025
Last Update
December 6 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Central Florida
Orlando, Florida, United States, 32816